可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Brown M, McGuinness M, Wright T, et al. Cardiac-specific blockade of NF-κB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo[J]. Am J Physiol Heart Circ Physiol, 2005, 289(1):H466-H476.
[2] Zhang M, Xu YJ, Saini HK, et al. Pentoxifylline attenuates cardiac dysfunction and reduces TNF-α level in ischemic-reperfused heart[J]. Am J Physiol Heart Circ Physiol, 2005, 289(2):H832-H839.
[3] Yeh CH, Chen TP, Wu YC, et al. Inhibition of NFκB activation with Curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia-reperfusion[J]. J Surg Res, 2005, 125(1):109-116.
[4] Liakopoulos OJ, Schmitto JD, Kazmaier F, et al. Cardiopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery[J]. Ann Thorac Surg, 2007, 84(1):110-118.
[5] Gu Q, Yang XP, Bonde P, et al. Inhibition of TNF-alpha reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog[J]. J Cardiovasc Pharmacol, 2006, 48(6):320-328.
[6] Shimamoto A, Chong AJ, Yada M, et al. Inhibition of Toll-like receptor 4 with Eritoran attenuates myocardial ischemia-reperfusion injury[J]. Circulation, 2006, 114(1 Suppl):I270-I274.
[7] Stansfield WE, Moss NC, Willis MS, et al. Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury[J]. Ann Thorac Surg, 2007, 84(1):120-125.
[8] Frantz S, Tillmanns J, Kuhlencordt PJ, et al. Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury[J]. Am J Pathol, 2007, 171(2):507-512.
[9] Choi H, Kim SH, Chun YS, et al. In vivo hyperoxic preconditioning prevents myocardial infarction by expressing Bcl-2[J]. Exp Biol Med, 2006, 231(4):463-472.
[10]Kin H, Wang NP, Halkos ME, et al. Neutrophil depletion reduces myocardial apoptosis and attenuates NFkappaB activation/TNFalpha release after ischemia and reperfusion[J]. J Surg Res, 2006, 135(1):170-178.
[11]郭瑞威,杨丽霞,石燕昆,等. NF-κB在TNF-α致人脐静脉内皮细胞凋亡中的作用[J]. 心脏杂志, 2006, 18(2):152-154.
[12]杨晓云,周宁,王琳,等. 辛伐他汀对NF-κB-DNA结合活性和表达的影响[J]. 心脏杂志, 2006, 14(4):369-372.
[13]Rui T, Kvietys PR. NFkappaB and AP-1 differentially contribute to the induction of MnSOD and eNOS during the development of oxidant tolerance[J]. FASEB J, 2005, 19(13):1908-1910.
[14]刘颖,吴伟康,陈晨,等. 核因子-κB在四逆汤预处理诱导大鼠心肌延迟预适应中的作用[J]. 中国中药杂志, 2005, 30(6):453-456.
[15]Li Q, Guo Y, Tan W, et al. Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-κB dependent pathway[J]. Circulation, 2007, 116(14):1577-1584.